Healthcare Triangle, Inc. (HCTI) - 10-K Summary
Business Context and Reporting Period
Company: Healthcare Triangle, Inc. (HCTI)
Filing Type: Annual Report on Form 10-K
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: HCTI is a healthcare information technology company providing cloud services, data science, and managed services to the Healthcare and Life Sciences (HCLS) industry. Key platforms include CloudEz, DataEz, Readabl.AI, Ziloy.AI, and Ezovion. The company operates in three segments: Software Services, Managed Services and Support, and Corporate & Others.
Key Financial Metrics (Year Ended Dec 31, 2025)
| Metric | 2025 (in '000s) | 2024 (in '000s) |
|---|---|---|
| Net Revenue | $13,891 | $11,696 |
| Cost of Revenue | $12,001 | $8,806 |
| Gross Margin | 13.6% | 24.7% |
| Net Loss | $(9,476) | $(5,969) |
| Operating Cash Flow | $(16,523) | $(1,081) |
| Cash & Equivalents (End of Period) | $7,625 | $20 |
| Short-Term Borrowing | $10,737 | $2,650 |
| Current Ratio | 1.03 | 0.33 |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 19% to $13.9 million, driven primarily by a 76% increase in Software Services revenue ($8.3M vs $4.7M). Managed Services revenue declined 20% to $5.4M.
- Margin Compression: Gross margin decreased significantly from 24.7% to 13.6%. Management attributes this to the acquisition of SecureKloud contracts which were negotiated at lower margins prior to the acquisition.
- Expense Increases: General and Administrative (G&A) expenses surged 86% to $7.3M, and Sales & Marketing expenses rose 40% to $3.1M, reflecting investments in growth and operations.
- Liquidity Improvement: Cash and cash equivalents increased from $20,000 to $7.6 million, primarily due to $25.9 million in financing activities (equity issuances and debt proceeds).
- Acquisitions: Completed the acquisition of Niyama Healthcare and Ezovion Solutions in June 2025, resulting in $2.9M in goodwill and $2.8M in intangible assets.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: Management expects future gross margins to increase materially as new contracts are negotiated at higher margins. The company is shifting focus toward recurring subscription-based revenue from its SaaS platforms (DataEz, CloudEz, Readabl.AI).
- Liquidity Status: Despite a net loss of $9.5M and negative operating cash flow, management concludes the company has sufficient resources to fund operations for at least 12 months, citing net assets of $9.9M and $9.8M in gross proceeds from equity issuance subsequent to year-end.
- Key Risks:
- Customer Concentration: Top 5 customers accounted for 58% of revenue in 2025.
- Related Party Dependence: Significant reliance on SecureKloud (a related party) for services, infrastructure, and resources. Advances to related parties totaled $3.8M.
- Debt Obligations: $10.5M in 2025 Convertible Notes (fair value) outstanding, maturing in 2026. Repayment depends on conversion or alternative financing.
- Control Structure: Series A Preferred Stock holders control approximately 96% of cumulative voting rights.
- Unusual Items:
- Reverse Stock Splits: A 1-for-249 reverse split occurred in August 2025, and a 1-for-60 reverse split occurred in February 2026 to maintain Nasdaq listing compliance.
- Other Income: Significant increase in other income to $857K (from $7K), largely due to changes in fair value of convertible debt and financing activities.
Investor Verification Checklist
- Debt Maturity: Verify the company's ability to refinance or convert the $10.5M in 2025 Convertible Notes maturing in November 2026.
- Margin Recovery: Monitor upcoming quarters to confirm if gross margins improve as management projects following the SecureKloud contract integration.
- Related Party Transactions: Review the terms and necessity of the $3.8M in advances to SecureKloud and the ongoing Master Service Agreement.
- Customer Retention: Assess the stability of the top 5 customers representing 58% of revenue.
- Subsequent Acquisitions: Review the terms of the January 2026 agreement to acquire Teyame AI (up to $50M purchase price) and its impact on future dilution and cash requirements.